Identification of a CK2 phosphorylation site in mdm2

European Journal of Biochemistry

Volumn 266, Issue 2, 1999, Pages 493-501

  Götz, Claudia ^a   Kartarius, Sabine ^a   Scholtes, Petra ^a   Nastainczyk, Wolfgang ^a   Montenarh, Mathias ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

mdm2; Oncogene; p53; Phosphorylation site; Protein kinase CK2

Indexed keywords

PROTEIN KINASE; PROTEIN P53; CASEIN KINASE II; MDM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PEPTIDE; PROTEIN MDM2; PROTEIN SERINE THREONINE KINASE; RECOMBINANT PROTEIN;

ARTICLE; BINDING SITE; CELL PROLIFERATION; COMPUTER ANALYSIS; DELETION MUTANT; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TRANSACTIVATION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; CODON; ESCHERICHIA COLI; HUMAN; INSECT; METABOLISM; MOLECULAR GENETICS; MUTATION; PHOSPHORYLATION; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BLOTTING, WESTERN; CASEIN KINASE II; CELL LINE; CODON; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; HUMANS; INSECTS; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR PROTEINS; PEPTIDES; PHOSPHORYLATION; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033486046     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00882.x     Document Type: Article

References (56)

1. 1. Cahilly-Snyder, L., Yang-Feng, T., Francke, U. & George, D.L. (1987) Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat. Cell Mol. Genet. 13, 235-244.
2. 2. Fakharzadeh, S.S., Trusko, S.P. & George, D.L. (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10, 1565-1569.
3. 3. Finlay, C.A. (1993) The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13, 301-306.
4. 4. Schlott, T., Reimer, S., Jahns, A., Ohlenbusch, A., Ruschenburg, I., Nagel, H. & Droese, M. (1997) Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumours. J. Pathol. 182, 54-61.
5. 5. Marchetti, A., Buttitta, F., Girlando, S., Dalla Palma, P., Pellegrini, S., Fina, P., Doglioni, C., Bevilacqua, G. & Barbareschi, M. (1995) mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J. Pathol. 175, 31-38.
6. 6. Leach, F.S., Tokino, T., Meltzer, P., Burrell, M., Oliner, J.D., Smith, S., Hill, D.E., Sidransky, D., Kinzler, K.W. & Vogelstein, B. (1993) p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53, 2231-2234.
7. 7. Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L. & Vogelstein, B. (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83.
8. 8. Olson, D.C., Marechal, V., Momand, J., Chen, J., Romocki, C. & Levine, A.J. (1993) Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 8, 2353-2360.
9. 9. Momand, J., Zambetti, G.P., Olson, D.C., George, D. & Levine, A.J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245.
10. 10. Barak, Y. & Oren, M. (1992) Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 11, 2115-2121.
11. 11. Wu, X., Bayle, J.H., Olson, D. & Levine, A.J. (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132.
12. 12. Barak, Y., Juven, T., Haffner, R. & Oren, M. (1993) mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468.
13. 13. Kubbutat, M.H.G., Ludwig, R.L., Ashcroft, M. & Vousden, K.H. (1998) Regulation of Mdm2-directed degradation by the C terminus of p53. Mol. Cell. Biol. 18, 5690-5698.
14. 14. Chen, J., Marechal, V. & Levine, A.J. (1993) Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13, 4107-4114.
15. 15. Roth, J., König, C., Wienzek, S., Weigel, S., Ristea, S. & Dobbelstein, M. (1998) Inactivation of p53 but not p73 by adenovirus type 5 EIB 55-kilodalton and E4, 34-kilodalton oncoproteins. J. Virol. 72, 8510-8516.
16. 16. Honda, R., Tanaka, H. & Yasuda, H. (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27.
17. 17. Xiao, Z.X., Chen, J., Levine, A.J., Modjtahedi, N., Xing, J., Sellers, W.R. & Livingston, D.M. (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375, 694-698.
18. 18. Martin, K., Trouche, D., Hagemeier, C., Sorensen, T.S., La Thangue, N.B. & Kouzarides, T. (1995) Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375, 691-694.
19. II250 and is required for MDM2 regulation of the cyclin A promoter. J. Biol. Chem. 272, 30651-30661.
20. 20. Elenbaas, B., Dobbelstein, M., Roth, J., Shenk, T. & Levine, A.J. (1996) The MDM2 oncoprotein binds specifically to RNA through its Ring finger domain. Mol. Med. 2, 439-451.
21. 21. Marechal, V., Elenbaas, B., Taneyhill, L., Piette, J., Mechali, M., Nicolas, J.C., Levine, A.J. & Moreau, J. (1997) Conservation of structural domains and biochemical activities of the MDM2 protein from Xenopus laevis. Oncogene 14, 1427-1433.
22. 22. Marechal, V., Elenbaas, B., Piette, J., Nicolas, J.-C. & Levine, A.J. (1994) The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14, 7414-7420.
23. 23. Brown, D.R., Thomas, C.A. & Deb, S.P. (1998) The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis. EMBO J. 17, 2513-2525.
24. 24. Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F. & Sherr, C.J. (1998) Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292-8297.
25. ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22-27.
26. 26. Shaulian, E., Resnitzky, D., Shifman, O., Blandino, G., Amsterdam, A., Yayon, A. & Oren, M. (1997) Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene 15, 2717-2725.
27. 27. Qi, J.S., Yuan, Y., Desai-Yajnik, V. & Samuels, H.H. (1999) Regulation of the mdm2 oncogene by thyroid hormone receptor. Mol. Cell Biol. 19, 864-872.
28. 28. Mayo, L.D., Turchi, J.J. & Berberich, S.J. (1997) Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. Cancer Res. 57, 5013-5016.
29. 29. Guerra, B., Götz, C., Wagner, P., Montenarh, M. & Issinger, O.-G. (1997) The carboxy terminus of p53 mimicks the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation. Oncogene 14, 2683-2688.
30. 30. Pinna, L.A. & Meggio, F. (1997) Protein kinase CK2 ('casein kinase-2') and its implication in cell division and proliferation. Prog. Cell Cycle Res. 3, 77-97.
31. 31. Guerra, B. & Issinger, O.G. (1999) Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20, 391-408.
32. 32. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-682.
33. 33. Padmanabha, R., Chen-Wu, J.L.P., Hanna, D.E. & Glover, C.V.C. (1990) Isolation, sequencing and disruption of the yeast CKA2 gene: casein kinase II is essential for viability in Saccharomyces cerevisiae. Mol. Cell. Biol. 10, 4089-4099.
34. 2/M in Saccharomyces cerevisiae. J. Biol. Chem. 270, 25905-25914.
35. 35. Pancetti, F., Bosser, R., Krehan, A., Pyerin, W., Itarte, E. & Bachs, O. (1999) Heterogeneous nuclear ribonucleoprotein A2 interacts with Protein Kinase CK2. Biochem. Biophys. Res. Comm. 260, 17-22.
36. 36. Ahmed, K. & Tawfic, S. (1994) Mechanism of intracellular regulation of protein kinase CK2: role of stimulus-mediated subnuclear association. Cell. Mol. Biol. Res. 40, 539-545.
37. 37. Zhang, P., Davis, A.T. & Ahmed, K. (1998) Mechanism of protein kinase CK2 association with nuclear matrix: role of disulfide bond formation. J. Cell. Biochem. 69, 211-220.
38. 38. Guo, C.H., Davis, A.T. & Ahmed, K. (1998) Dynamics of protein kinase CK2 association with nucleosomes in relation to transcriptional activity. J. Biol. Chem. 273, 13675-13680.
39. 39. Tuteja, N., Huang, N.W., Skopac, D., Tuteja, R., Hrvatic, S., Zhang, J., Pongor, S., Joseph, G., Faucher, C., Amalric, F. & Falaschi, A. (1995) Human DNA helicase IV is nucleolin, an RNA helicase modulated by phosphorylation. Gene 160, 143-148.
40. 40. Guerra, B. & Issinger, O.G. (1998) p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment. FEBS Lett. 434, 115-120.
41. 41. Kim, J.M., Cha, J.Y., Marshak, D.R. & Bae, Y.S. (1996) Interaction of the β subunit of casein kinase II with the ribosomal protein L5. Biochem. Biophys. Res. Commun. 226, 180-186.
42. 42. Münstermann, U., Fritz, G., Seitz, G., Yiping, L., Schneider, H.R. & Issinger, O.-G. (1990) Casein kinase II is elevated in human tumours and rapidly proliferating non-neoplastic tissue. Eur. J. Biochem. 189, 251-257.
43. 43. Prowald, K., Fischer, H. & Issinger, O.G. (1984) Enhanced casein kinase II activity in human tumour cell cultures. FEBS Lett 176, 479-483.
44. 44. Stalter, G., Siemer, S., Becht, E., Ziegler, M., Remberger, K. & Issinger, O.-G. (1994) Asymmetric expression of protein kinase CK2 in human kidney tumors. Biochem. Biophys. Res. Commun. 202, 141-147.
45. 45. Henning, W., Rohaly, G., Kolzau, T., Knippschild, U., Maacke, H. & Deppert, W. (1997) MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection. J. Virol. 71, 7609-7618.
46. 46. Boldyreff, B., Meggio, F., Pinna, L.A. & Issinger, O.-G. (1994) Protein kinase CK2 structure-function relationship: effects of the β subunit on reconstitution and activity. Cell. Mol. Biol. Res. 40, 391-399.
47. 47. Marshak, D.R. & Carroll, D. (1991) Synthetic peptide substrates for casein kinase II. Methods Enzymol. 200, 134-156.
48. 48. Kuenzel, E.A., Mulligan, J.A., Sommercom, J. & Krebs, E.G. (1987) Substrate specificity determinants for casein kinase II as deduced from studies with synthetic peptides. J. Biol. Chem. 262, 9136-9140.
49. 49. Pinna, L.A. (1990) Casein kinase 2: an 'eminence grise' in cellular regulation. Biochim. Biophys. Acta Mol. Cell Res. 1054, 267-284.
50. 50. Freedman, D.A., Wu, L. & Levine, A.J. (1999) Functions of the MDM2 oncoprotein. Cell. Mol. Life Sci. 55, 96-107.
51. 51. Erhardt, P., Tomaselli, K.J. & Cooper, G.M. (1997) Identification of the MDM2 oncoprotein as a substrate for CPP.32-like apoptotic proteases. J. Biol. Chem. 272, 15049-15052.
52. 52. Chen, L.H., Marechal, V., Moreau, J., Levine, A.J. & Chen, J.D. (1997) Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J. Biol. Chem. 272, 22966-22973.
53. 53. Pochampally, R., Fodera, B., Chen, L.H., Shao, W.J., Levine, E.A. & Chen, J.D. (1998) A 60 kd MDM2 isoform is produced by caspase cleavage in non-apoptotic tumor cells. Oncogene 17, 2629-2636.
54. 54. Leng, P., Brown, D.R. & Deb, S.P. (1995) Human oncoprotein MDM2 interacts with the TATA-binding protein in vitro and in vivo. Int. J. Oncol. 6, 251-259.
55. 55. Kussie, P.H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A.J. & Pavletich, N.P. (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948-953.
56. 56. Hupp, T.R. & Lane, D.P. (1994) Allosteric activation of latent p53 tetramers. Curr. Biol. 4, 865-875.